Foundations Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-8,286
Closed -$212K – 842
2024
Q3
$212K Sell
8,286
-717
-8% -$18.3K ﹤0.01% 757
2024
Q2
$211K Sell
9,003
-450
-5% -$11.4K 0.01% 710
2024
Q1
$272K Sell
9,453
-2,587
-21% -$77.8K 0.01% 601
2023
Q4
$350K Sell
12,040
-2,867
-19% -$78K 0.01% 517
2023
Q3
$415K Sell
14,907
-48,643
-77% -$1.59M 0.01% 432
2023
Q2
$2.17M Sell
63,550
-3,753
-6% -$118K 0.07% 184
2023
Q1
$2.02M Sell
67,303
-4,256
-6% -$132K 0.07% 163
2022
Q4
$2.02M Sell
71,559
-3,029
-4% -$96.1K 0.08% 130
2022
Q3
$2.45M Sell
74,588
-6,855
-8% -$252K 0.11% 82
2022
Q2
$2.88M Sell
81,443
-1,586
-2% -$55.5K 0.12% 79
2022
Q1
$3.52M Sell
83,029
-4,846
-6% -$231K 0.14% 62
2021
Q4
$4.69M Buy
87,875
+8,681
+11% +$600K 0.18% 51
2021
Q3
$5.76M Buy
79,194
+3,658
+5% +$307K 0.25% 34
2021
Q2
$6.8M Buy
+75,536
New +$6.42M 0.33% 38

Other funds holding ARKG

Foundations Investment Advisors's ARKG Position: Q4 2024 in Review

Foundations Investment Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 8,286 shares — an estimated $212K sold.

Foundations Investment Advisors first reported a position in ARKG in Q2 2021 and held it in 14 quarters. The position peaked at $6.8M in Q2 2021. 241 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Foundations Investment Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Foundations Investment Advisors sold 8,286 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $212K.
  • Foundations Investment Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 14 quarters.
  • Foundations Investment Advisors's ARK Genomic Revolution ETF position peaked at $6.8M in Q2 2021.
  • 241 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Foundations Investment Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.